Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue factor pathway inhibitor (TFPI)

M Rucińska1, M Gacko, Z Skrzydlewski

  • 1Department of Oncology, Medical Academy of Białystok.

Roczniki Akademii Medycznej W Bialymstoku (1995)
|January 1, 1997
PubMed
Summary

Tissue factor pathway inhibitor (TFPI) regulates blood coagulation. Increasing TFPI activity inhibits fibrin formation, while decreasing it promotes coagulation and fibrin deposition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer related information that cancer patients need.

Scientific reports·2025
Same author

Health care system and patient-related factors affecting low cancer screening participation in Poland.

Preventive medicine reports·2023
Same author

Conservation and storage of a haploid cucumber (Cucumis sativus L.) collection under in vitro conditions.

Plant cell reports·2019
Same author

Prospective Assessment of Hepcidin in Relation to Delayed or Immediate Graft Function in Patients Undergoing Kidney Transplantation.

Transplantation proceedings·2016
Same author

Diet and the content of selenium and lead in patients with abdominal aortic aneurysm.

VASA. Zeitschrift fur Gefasskrankheiten·2011
Same author

Renal parenchyma perfusion spectrum and resistive index (RI) in ultrasound examinations with contrast medium in the early period after kidney transplantation.

Transplantation proceedings·2009

Area of Science:

  • Biochemistry
  • Hematology

Background:

  • Tissue factor pathway inhibitor (TFPI) is a key plasma proteinase inhibitor involved in regulating blood coagulation.
  • TFPI is a 42 kD glycoprotein synthesized by vascular endothelial cells, with its sequence being well-characterized.
  • It exists in both free (active) and lipoprotein-associated (nonactive) forms in circulation.

Purpose of the Study:

  • To elucidate the role of TFPI in modulating blood coagulation.
  • To understand the mechanisms by which TFPI influences Factor Xa and the Factor VIIa/TF complex.
  • To explore the impact of varying TFPI activity on fibrin formation.

Main Methods:

  • Biochemical analysis of TFPI structure and function.
  • Assays to measure TFPI inhibition of activated Factor Xa.
  • Evaluation of TFPI interaction with the Factor VIIa/TF complex.
  • Assessment of coagulation and fibrin formation under different TFPI activity levels.

Main Results:

  • TFPI directly inhibits activated Factor Xa.
  • TFPI further inhibits the Factor VIIa/TF complex.
  • Reduced TFPI activity accelerates blood coagulation and fibrin formation.
  • Elevated TFPI activity suppresses coagulation and fibrin deposition.

Conclusions:

  • TFPI is a critical inhibitor of the extrinsic coagulation pathway.
  • Modulating TFPI activity offers a potential therapeutic target for controlling hemostasis.
  • Understanding TFPI's function is essential for managing thrombotic and bleeding disorders.

Related Experiment Videos